SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-19-020479
Filing Date
2019-05-24
Accepted
2019-05-24 16:31:19
Documents
1
Effectiveness Date
2019-05-24

Document Format Files

Seq Description Document Type Size
1 DEFA14A sbph-defa14a_20190710.htm DEFA14A 50331
  Complete submission text file 0001564590-19-020479.txt   51361
Mailing Address 35 PARKWOOD DRIVE SUITE 210 HOPKINTON MA 01748
Business Address 35 PARKWOOD DRIVE SUITE 210 HOPKINTON MA 01748 508-473-5993 X119
Spring Bank Pharmaceuticals, Inc. (Filer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37718 | Film No.: 19854865
SIC: 2834 Pharmaceutical Preparations